Results 111 to 120 of about 1,973 (178)

Real-World Evidence for Sevelamer vs Calcium-Containing Phosphate Binders in Long-Term Effectiveness and Safety Among Patients with Non-Dialysis CKD: The REVEAL Study. [PDF]

Adv Ther
Li P, Li C, Liang S, Sun X, Guo X, Xu X, Hao L, Chen X, Feng Z, Cai G.   +9 more
europepmc   +1 more source

Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure. [PDF]

Biomed Res Int, 2015
Phan O, Maillard M, Malluche HH, Stehle JC, Funk F, Burnier M.   +5 more
europepmc   +1 more source

Emerging treatments and current strategies for mineral, vascular, and bone disorders in chronic kidney disease. [PDF]

World J Nephrol
Ilkun O, Jazayeri F, Kazory A.
europepmc   +1 more source

Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland. [PDF]

Pharmacoeconomics, 2015
Gutzwiller FS, Pfeil AM, Ademi Z, Blank PR, Braunhofer PG, Szucs TD, Schwenkglenks M.   +6 more
europepmc   +1 more source

The role of nutritional vitamin D on microinflammation and nutritional status in maintenance hemodialysis patients: a meta-analysis of randomized controlled trials. [PDF]

Front Nutr
Li C, Xu S, Wang Y, Wu M.
europepmc   +1 more source

Association between sevelamer use and outcomes in acute kidney injury with hyperphosphataemia: evidence from the MIMIC-IV. [PDF]

Front Pharmacol
Suo S, Yang Q, Chen W, Luo L, Song Y, Ling C, Wang J, Wen D, Liu C.   +8 more
europepmc   +1 more source

Efficacy and Safety of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in Chinese Dialysis Patients with Hyperphosphataemia: A Randomised, Open-Label, Multicentre, 12-Week Phase III Study.

Nephron
Liu J, Zuo L, Walpen S, Bernard L, Marty M, Enoiu M.   +5 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Phosphorus-Lowering Drugs for CKD 3-5 Stages. [PDF]

Kidney Med
Hou W, Xie P, Fu Y, Wang C, Wang K, Sun Y, Wei W, Xu L, Su C.   +8 more
europepmc   +1 more source

Evanescent extraosseous calcifications in low turnover bone: management and outcomes: a case report. [PDF]

Front Nephrol
Hernandez-Pérez M, Enos D.
europepmc   +1 more source

Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift. [PDF]

J Gerontol A Biol Sci Med Sci, 2012
Vlassara H, Cai W, Chen X, Serrano EJ, Shobha MS, Uribarri J, Woodward M, Striker GE.   +7 more
europepmc   +1 more source